| Product Code: ETC9964610 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Drug Discovery Outsourcing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Drug Discovery Outsourcing Market - Industry Life Cycle |
3.4 United States (US) Drug Discovery Outsourcing Market - Porter's Five Forces |
3.5 United States (US) Drug Discovery Outsourcing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Molecule, 2021 & 2031F |
3.7 United States (US) Drug Discovery Outsourcing Market Revenues & Volume Share, By Discovery Approach, 2021 & 2031F |
3.8 United States (US) Drug Discovery Outsourcing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 United States (US) Drug Discovery Outsourcing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 United States (US) Drug Discovery Outsourcing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United States (US) Drug Discovery Outsourcing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing complexity in drug discovery processes leading to the need for specialized expertise |
4.2.2 Growing demand for cost-effective solutions and efficiency in drug development |
4.2.3 Rise in research and development activities by pharmaceutical and biotechnology companies |
4.3 Market Restraints |
4.3.1 Data security and confidentiality concerns in outsourcing drug discovery activities |
4.3.2 Regulatory challenges and compliance requirements impacting outsourcing decisions |
4.3.3 Risk of intellectual property theft and loss of control over the drug discovery process |
5 United States (US) Drug Discovery Outsourcing Market Trends |
6 United States (US) Drug Discovery Outsourcing Market, By Types |
6.1 United States (US) Drug Discovery Outsourcing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Chemical Services, 2021- 2031F |
6.1.4 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Biology Services, 2021- 2031F |
6.2 United States (US) Drug Discovery Outsourcing Market, By Drug Molecule |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.2.3 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Large Molecules, 2021- 2031F |
6.3 United States (US) Drug Discovery Outsourcing Market, By Discovery Approach |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Empirical Drug Discovery, 2021- 2031F |
6.3.3 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Rational Drug Discovery, 2021- 2031F |
6.4 United States (US) Drug Discovery Outsourcing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Target Identification and Screening, 2021- 2031F |
6.4.3 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Lead Identification and Candidate Optimization, 2021- 2031F |
6.4.4 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Development of Disease Models, 2021- 2031F |
6.4.5 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Pre-formulation Studies, 2021- 2031F |
6.4.6 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Entire Clinical Trials, 2021- 2031F |
6.4.7 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Drug Discovery Outsourcing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Anti-infective, 2021- 2031F |
6.5.3 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.5.4 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Central Nervous System, 2021- 2031F |
6.5.5 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.5.6 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Endocrine, 2021- 2031F |
6.5.7 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.5.8 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Drug Discovery Outsourcing Market, By End-user |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.6.3 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.6.4 United States (US) Drug Discovery Outsourcing Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
7 United States (US) Drug Discovery Outsourcing Market Import-Export Trade Statistics |
7.1 United States (US) Drug Discovery Outsourcing Market Export to Major Countries |
7.2 United States (US) Drug Discovery Outsourcing Market Imports from Major Countries |
8 United States (US) Drug Discovery Outsourcing Market Key Performance Indicators |
8.1 Percentage of cost savings achieved through outsourcing drug discovery activities |
8.2 Number of successful drug discoveries attributed to outsourcing partnerships |
8.3 Rate of adoption of advanced technologies and tools in outsourced drug discovery projects |
9 United States (US) Drug Discovery Outsourcing Market - Opportunity Assessment |
9.1 United States (US) Drug Discovery Outsourcing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Molecule, 2021 & 2031F |
9.3 United States (US) Drug Discovery Outsourcing Market Opportunity Assessment, By Discovery Approach, 2021 & 2031F |
9.4 United States (US) Drug Discovery Outsourcing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 United States (US) Drug Discovery Outsourcing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 United States (US) Drug Discovery Outsourcing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United States (US) Drug Discovery Outsourcing Market - Competitive Landscape |
10.1 United States (US) Drug Discovery Outsourcing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here